Myriad Genetics Inc (MYGN): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

92.60M
Year ended 2025-12-31
+4.7%
3-year compound annual growth
+4.4%
5-year compound annual growth
99.15M2009-06-30: 98.57M2010-06-30: 99.15M2011-06-30: 91.70M2012-06-30: 86.47M2013-06-30: 83.30M2014-06-30: 78.20M2015-06-30: 74.50M2016-06-30: 73.40M2017-06-30: 68.80M2018-06-30: 72.00M2019-06-30: 76.00M2020-12-31: 74.80M2021-12-31: 78.00M2022-12-31: 80.60M2023-12-31: 82.80M2024-12-31: 90.60M2025-12-31: 92.60M92.60M
2009-06-30 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3192.60M+2.2%2026-02-24, From 2025-01-01
2024-12-3190.60M+9.4%2026-02-24, From 2024-01-01
2023-12-3182.80M+2.7%2026-02-24, From 2023-01-01
2022-12-3180.60M+3.3%2025-02-28, From 2022-01-01
2021-12-3178.00M+4.3%2024-02-28, From 2021-01-01
2020-12-3174.80Mn/a2022-02-25, From 2020-01-01
No annual figure between 2019-06-30 and 2020-12-31.
2019-06-3076.00M+5.6%2022-02-25, From 2018-07-01
2018-06-3072.00M+4.7%2020-08-13, From 2017-07-01
2017-06-3068.80M-6.3%2019-08-13, From 2016-07-01
2016-06-3073.40M-1.5%2018-08-24, From 2015-07-01
2015-06-3074.50M-4.7%2018-08-24, From 2014-07-01
2014-06-3078.20M-6.1%2016-08-10, From 2013-07-01
2013-06-3083.30M-3.7%2015-08-12, From 2012-07-01
2012-06-3086.47M-5.7%2014-08-13, From 2011-07-01
2011-06-3091.70M-7.5%2013-08-14, From 2010-07-01
2010-06-3099.15M+0.6%2012-08-15, From 2009-07-01
2009-06-3098.57Mn/a2011-08-15, From 2008-07-01